314 related articles for article (PubMed ID: 12490596)
1. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.
Kurrasch-Orbaugh DM; Watts VJ; Barker EL; Nichols DE
J Pharmacol Exp Ther; 2003 Jan; 304(1):229-37. PubMed ID: 12490596
[TBL] [Abstract][Full Text] [Related]
2. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
Berg KA; Maayani S; Goldfarb J; Scaramellini C; Leff P; Clarke WP
Mol Pharmacol; 1998 Jul; 54(1):94-104. PubMed ID: 9658194
[TBL] [Abstract][Full Text] [Related]
3. Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism.
Parrish JC; Nichols DE
J Neurochem; 2006 Nov; 99(4):1164-75. PubMed ID: 17010161
[TBL] [Abstract][Full Text] [Related]
4. A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases.
Kurrasch-Orbaugh DM; Parrish JC; Watts VJ; Nichols DE
J Neurochem; 2003 Aug; 86(4):980-91. PubMed ID: 12887695
[TBL] [Abstract][Full Text] [Related]
5. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
[TBL] [Abstract][Full Text] [Related]
6. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
Xu J; Jian B; Chu R; Lu Z; Li Q; Dunlop J; Rosenzweig-Lipson S; McGonigle P; Levy RJ; Liang B
Am J Pathol; 2002 Dec; 161(6):2209-18. PubMed ID: 12466135
[TBL] [Abstract][Full Text] [Related]
7. Serotonin-2A homodimers are needed for signalling via both phospholipase A
Iglesias A; Cimadevila M; Cadavid MI; Loza MI; Brea J
Eur J Pharmacol; 2017 Apr; 800():63-69. PubMed ID: 28216047
[TBL] [Abstract][Full Text] [Related]
8. Differential phospholipase C activation by phenylalkylamine serotonin 5-HT 2A receptor agonists.
Parrish JC; Braden MR; Gundy E; Nichols DE
J Neurochem; 2005 Dec; 95(6):1575-84. PubMed ID: 16277614
[TBL] [Abstract][Full Text] [Related]
9. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
Schindler EA; Harvey JA; Aloyo VJ
Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
[TBL] [Abstract][Full Text] [Related]
11. Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (+/-)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI).
Qu Y; Chang L; Klaff J; Balbo A; Rapoport SI
Neuropsychopharmacology; 2003 Feb; 28(2):244-52. PubMed ID: 12589377
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of regulation of agonist efficacy at the 5-HT(1A) receptor by phospholipid-derived signaling components.
Evans KL; Cropper JD; Berg KA; Clarke WP
J Pharmacol Exp Ther; 2001 Jun; 297(3):1025-35. PubMed ID: 11356925
[TBL] [Abstract][Full Text] [Related]
13. 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
Berg KA; Maayani S; Clarke WP
Mol Pharmacol; 1996 Oct; 50(4):1017-23. PubMed ID: 8863849
[TBL] [Abstract][Full Text] [Related]
14. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
[TBL] [Abstract][Full Text] [Related]
15. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Berg KA; Cropper JD; Niswender CM; Sanders-Bush E; Emeson RB; Clarke WP
Br J Pharmacol; 2001 Sep; 134(2):386-92. PubMed ID: 11564657
[TBL] [Abstract][Full Text] [Related]
16. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
[TBL] [Abstract][Full Text] [Related]
17. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.
Damjanoska KJ; Heidenreich BA; Kindel GH; D'Souza DN; Zhang Y; Garcia F; Battaglia G; Wolf WA; Van de Kar LD; Muma NA
J Pharmacol Exp Ther; 2004 Jun; 309(3):1043-50. PubMed ID: 14976228
[TBL] [Abstract][Full Text] [Related]
18. Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence.
Stout BD; Clarke WP; Berg KA
J Pharmacol Exp Ther; 2002 Sep; 302(3):957-62. PubMed ID: 12183652
[TBL] [Abstract][Full Text] [Related]
19. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
Wolf WA; Schutz LJ
J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
[TBL] [Abstract][Full Text] [Related]
20. Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein.
Shi J; Damjanoska KJ; Zemaitaitis B; Garcia F; Carrasco G; Sullivan NR; She Y; Young KH; Battaglia G; Van De kar LD; Howland DS; Muma NA
Neuropharmacology; 2006 Sep; 51(3):524-35. PubMed ID: 16769091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
